Point Of Care Diagnostics In 2022: New Technology But Old Problems
Following a busy year for point of care diagnostics, the industry is facing a period of consolidation. The drive for new technologies is being countered by regulatory and financial issues.
You may also be interested in...
Exec Chat: MeMed Improves Diagnostics To Combat Antimicrobial resistance
Kfir Oved, co-founder and CTO of MeMed, talked to Medtech Insight about diagnostic testing that can differentiate bacterial and viral infections to fight antimicrobial resistance.
EU Is Heading For Partial IVD Market Collapse, Recent Analysis And Figures Suggest
With just six notified bodies designated under the IVD Regulation, and amidst repeated warnings of insufficient auditing capacity, the EU could lose between three-quarters and over a half of its IVDs, a recent survey warns.
MeMed’s Mission: Pressing Its Fingerprint Against AMR
Approved in Europe and just given the US green light, MeMed is making waves in the fight against antimicrobial resistance using advanced "host response" technology. Its CEO talks to In Vivo about strategy, commercialization and earning the right to fantasize.